Altimmune Inc (ALT)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Vipin K. Garg
Employees:
50
910 CLOPPER ROAD, SUITE 201S, GAITHERSBURG, MD, 20878
2406541450
-
Formally known as:
- Healthcare Acquisition Corp
Are you looking for this stock instead?
Date | Ratio |
---|---|
2018-09-14 | 1:30 |
Altimmune, Inc. focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatitis.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|